FDA clears Saluda Medical's CAP24 paddle lead for spinal cord stimulation
Saluda Medical (ASX: SLD) announced that the U.S. Food and Drug Administration has approved its CAP24 surgical paddle lead, allowing ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
